167 related articles for article (PubMed ID: 27788391)
1. One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.
Kalkman DN; Woudstra P; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
Int J Cardiol; 2017 Jan; 226():60-64. PubMed ID: 27788391
[TBL] [Abstract][Full Text] [Related]
2. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
[TBL] [Abstract][Full Text] [Related]
3. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
de Winter RJ; Chandrasekhar J; Kalkman DN; Aquino MB; Woudstra P; Beijk MA; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; ;
JACC Cardiovasc Interv; 2018 Oct; 11(19):1969-1978. PubMed ID: 30286855
[TBL] [Abstract][Full Text] [Related]
4. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
5. Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Kalkman DN; Kerkmeijer LS; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2019 Sep; 94(3):342-347. PubMed ID: 30565371
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non-Insulin-Treated Diabetes Mellitus: Secondary Analysis of the TUXEDO Trial.
Bangalore S; Bhagwat A; Pinto B; Goel PK; Jagtap P; Sathe S; Arambam P; Kaul U
JAMA Cardiol; 2016 Jun; 1(3):266-73. PubMed ID: 27438104
[TBL] [Abstract][Full Text] [Related]
8. Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus.
Hoebers LP; Claessen BE; Woudstra P; DeVries JH; Wykrzykowska JJ; Vis MM; Baan J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
EuroIntervention; 2014 May; 10(1):90-6. PubMed ID: 24832639
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
Colombo A; Chandrasekhar J; Aquino M; Ong TK; Sartori S; Baber U; Lee M; Iniguez A; Hajek P; Borisov B; Atzev B; Den Heijer P; Coufal Z; Hudec M; Mates M; Snyder C; Moalem K; Morrell D; Elmore F; Rowland S; Mehran R;
Int J Cardiol; 2019 May; 283():67-72. PubMed ID: 30826192
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
11. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration.
Chandrasekhar J; Kalkman DN; Aquino MB; Sartori S; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Schee A; Munawar M; Gerber RT; Yan BP; Tejedor P; Kala P; Liew HB; Lee M; Baber U; Vogel B; Dangas GD; Colombo A; de Winter RJ; Mehran R; ;
Int J Cardiol; 2020 May; 307():17-23. PubMed ID: 32111358
[TBL] [Abstract][Full Text] [Related]
12. Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Kerkmeijer LSM; Chandrasekhar J; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
Catheter Cardiovasc Interv; 2021 Sep; 98(3):503-510. PubMed ID: 33029937
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
Hillegass WB; Patel MR; Klein LW; Gurm HS; Brennan JM; Anstrom KJ; Dai D; Eisenstein EL; Peterson ED; Messenger JC; Douglas PS
J Am Coll Cardiol; 2012 Dec; 60(22):2280-9. PubMed ID: 23194940
[TBL] [Abstract][Full Text] [Related]
14. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration.
Chandrasekhar J; Zeebregts D; Kalkman DN; Sartori S; Roumeliotis A; Aquino MB; de Wilde P; de Winter VC; Baber U; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Lee M; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; de Winter RJ;
Cardiovasc Revasc Med; 2020 Dec; 21(12):1542-1547. PubMed ID: 32507695
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis.
Kalkman DN; Kok MM; van der Heijden LC; Woudstra P; Beijk MAM; Tijssen JGP; von Birgelen C; de Winter RJ
EuroIntervention; 2017 Nov; 13(10):1202-1209. PubMed ID: 28870878
[TBL] [Abstract][Full Text] [Related]
16. Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.
Harada Y; Colleran R; Kufner S; Giacoppo D; Rheude T; Michel J; Cassese S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
Cardiovasc Diabetol; 2016 Sep; 15(1):124. PubMed ID: 27586678
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era.
Pi SH; Rhee TM; Lee JM; Hwang D; Park J; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Kim BJ; Kim BS; Gwon HC; Choi SH
Am J Cardiol; 2018 Jun; 121(12):1505-1511. PubMed ID: 29751955
[TBL] [Abstract][Full Text] [Related]
18. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.
Li N; Yang YG; Chen MH
BMC Cardiovasc Disord; 2016 Nov; 16(1):238. PubMed ID: 27887590
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial.
Jiménez-Quevedo P; Hernando L; Gómez-Hospital JA; Iñiguez A; SanRoman A; Alfonso F; Hernández-Antolín R; Angiolillo DJ; Bañuelos C; Escaned J; Gonzalo N; Fernández C; Macaya C; Sabaté M;
EuroIntervention; 2013 Jul; 9(3):328-35. PubMed ID: 23518240
[TBL] [Abstract][Full Text] [Related]
20. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
Haude M; Lee SW; Worthley SG; Silber S; Verheye S; Erbs S; Rosli MA; Botelho R; Meredith I; Sim KH; Stella PR; Tan HC; Whitbourn R; Thambar S; Abizaid A; Koh TH; Den Heijer P; Parise H; Cristea E; Maehara A; Mehran R
JACC Cardiovasc Interv; 2013 Apr; 6(4):334-43. PubMed ID: 23523459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
